TY - JOUR A1 - Svensson, Sarah L. A1 - Sharma, Cynthia M. T1 - Small RNAs that target G-rich sequences are generated by diverse biogenesis pathways in Epsilonproteobacteria JF - Molecular Microbiology N2 - Bacterial small RNAs (sRNAs) are widespread post-transcriptional regulators that control bacterial stress responses and virulence. Nevertheless, little is known about how they arise and evolve. Homologs can be difficult to identify beyond the strain level using sequence-based approaches, and similar functionalities can arise by convergent evolution. Here, we found that the virulence-associated CJnc190 sRNA of the foodborne pathogen Campylobacter jejuni resembles the RepG sRNA from the gastric pathogen Helicobacter pylori. However, while both sRNAs bind G-rich sites in their target mRNAs using a C/U-rich loop, they largely differ in their biogenesis. RepG is transcribed from a stand-alone gene and does not require processing, whereas CJnc190 is transcribed from two promoters as precursors that are processed by RNase III and also has a cis-encoded antagonist, CJnc180. By comparing CJnc190 homologs in diverse Campylobacter species, we show that RNase III-dependent processing of CJnc190 appears to be a conserved feature even outside of C. jejuni. We also demonstrate the CJnc180 antisense partner is expressed in C. coli, yet here might be derived from the 3’UTR (untranslated region) of an upstream flagella-related gene. Our analysis of G-tract targeting sRNAs in Epsilonproteobacteria demonstrates that similar sRNAs can have markedly different biogenesis pathways. KW - sRNA biogenesis KW - Campylobacter jejuni KW - Helicobacter pylori KW - pathogenesis KW - RNase III Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259602 VL - 117 ER - TY - JOUR A1 - El Mouali, Youssef A1 - Gerovac, Milan A1 - Mineikaitė, Raminta A1 - Vogel, Jörg T1 - In vivo targets of Salmonella FinO include a FinP-like small RNA controlling copy number of a cohabitating plasmid JF - Nucleic Acids Research N2 - FinO-domain proteins represent an emerging family of RNA-binding proteins (RBPs) with diverse roles in bacterial post-transcriptional control and physiology. They exhibit an intriguing targeting spectrum, ranging from an assumed single RNA pair (FinP/traJ) for the plasmid-encoded FinO protein, to transcriptome-wide activity as documented for chromosomally encoded ProQ proteins. Thus, the shared FinO domain might bear an unusual plasticity enabling it to act either selectively or promiscuously on the same cellular RNA pool. One caveat to this model is that the full suite of in vivo targets of the assumedly highly selective FinO protein is unknown. Here, we have extensively profiled cellular transcripts associated with the virulence plasmid-encoded FinO in Salmonella enterica. While our analysis confirms the FinP sRNA of plasmid pSLT as the primary FinO target, we identify a second major ligand: the RepX sRNA of the unrelated antibiotic resistance plasmid pRSF1010. FinP and RepX are strikingly similar in length and structure, but not in primary sequence, and so may provide clues to understanding the high selectivity of FinO-RNA interactions. Moreover, we observe that the FinO RBP encoded on the Salmonella virulence plasmid controls the replication of a cohabitating antibiotic resistance plasmid, suggesting cross-regulation of plasmids on the RNA level. KW - antisense RNA KW - Escherichia coli KW - chromosomal genes KW - protein KW - chaperone KW - virulence KW - family KW - HFQ KW - specificity KW - inhibition Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-261072 VL - 49 IS - 9 ER - TY - JOUR A1 - Ramírez-Zavala, Bernardo A1 - Krüger, Ines A1 - Dunker, Christine A1 - Jacobsen, Ilse D. A1 - Morschhäuser, Joachim T1 - The protein kinase Ire1 has a Hac1-independent essential role in iron uptake and virulence of Candida albicans JF - PLoS Pathogens N2 - Protein kinases play central roles in virtually all signaling pathways that enable organisms to adapt to their environment. Microbial pathogens must cope with severely restricted iron availability in mammalian hosts to invade and establish themselves within infected tissues. To uncover protein kinase signaling pathways that are involved in the adaptation of the pathogenic yeast Candida albicans to iron limitation, we generated a comprehensive protein kinase deletion mutant library of a wild-type strain. Screening of this library revealed that the protein kinase Ire1, which has a conserved role in the response of eukaryotic cells to endoplasmic reticulum stress, is essential for growth of C. albicans under iron-limiting conditions. Ire1 was not necessary for the activity of the transcription factor Sef1, which regulates the response of the fungus to iron limitation, and Sef1 target genes that are induced by iron depletion were normally upregulated in ire1Δ mutants. Instead, Ire1 was required for proper localization of the high-affinity iron permease Ftr1 to the cell membrane. Intriguingly, iron limitation did not cause increased endoplasmic reticulum stress, and the transcription factor Hac1, which is activated by Ire1-mediated removal of the non-canonical intron in the HAC1 mRNA, was dispensable for Ftr1 localization to the cell membrane and growth under iron-limiting conditions. Nevertheless, expression of a pre-spliced HAC1 copy in ire1Δ mutants restored Ftr1 localization and rescued the growth defects of the mutants. Both ire1Δ and hac1Δ mutants were avirulent in a mouse model of systemic candidiasis, indicating that an appropriate response to endoplasmic reticulum stress is important for the virulence of C. albicans. However, the specific requirement of Ire1 for the functionality of the high-affinity iron permease Ftr1, a well-established virulence factor, even in the absence of endoplasmic reticulum stress uncovers a novel Hac1-independent essential role of Ire1 in iron acquisition and virulence of C. albicans. KW - protein kinase KW - Ire1 KW - Candida albicans Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-300225 VL - 18 IS - 2 ER - TY - JOUR A1 - Gupta, Shishir K. A1 - Srivastava, Mugdha A1 - Minocha, Rashmi A1 - Akash, Aman A1 - Dangwal, Seema A1 - Dandekar, Thomas T1 - Alveolar regeneration in COVID-19 patients: a network perspective JF - International Journal of Molecular Sciences N2 - A viral infection involves entry and replication of viral nucleic acid in a host organism, subsequently leading to biochemical and structural alterations in the host cell. In the case of SARS-CoV-2 viral infection, over-activation of the host immune system may lead to lung damage. Albeit the regeneration and fibrotic repair processes being the two protective host responses, prolonged injury may lead to excessive fibrosis, a pathological state that can result in lung collapse. In this review, we discuss regeneration and fibrosis processes in response to SARS-CoV-2 and provide our viewpoint on the triggering of alveolar regeneration in coronavirus disease 2019 (COVID-19) patients. KW - COVID-19 KW - SARS-CoV-2 KW - alveolar regeneration KW - alveolar fibrosis KW - signaling pathway KW - network biology Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-284307 SN - 1422-0067 VL - 22 IS - 20 ER - TY - JOUR A1 - Jiang, Yuxiang A1 - Oron, Tal Ronnen A1 - Clark, Wyatt T. A1 - Bankapur, Asma R. A1 - D'Andrea, Daniel A1 - Lepore, Rosalba A1 - Funk, Christopher S. A1 - Kahanda, Indika A1 - Verspoor, Karin M. A1 - Ben-Hur, Asa A1 - Koo, Da Chen Emily A1 - Penfold-Brown, Duncan A1 - Shasha, Dennis A1 - Youngs, Noah A1 - Bonneau, Richard A1 - Lin, Alexandra A1 - Sahraeian, Sayed M. E. A1 - Martelli, Pier Luigi A1 - Profiti, Giuseppe A1 - Casadio, Rita A1 - Cao, Renzhi A1 - Zhong, Zhaolong A1 - Cheng, Jianlin A1 - Altenhoff, Adrian A1 - Skunca, Nives A1 - Dessimoz, Christophe A1 - Dogan, Tunca A1 - Hakala, Kai A1 - Kaewphan, Suwisa A1 - Mehryary, Farrokh A1 - Salakoski, Tapio A1 - Ginter, Filip A1 - Fang, Hai A1 - Smithers, Ben A1 - Oates, Matt A1 - Gough, Julian A1 - Törönen, Petri A1 - Koskinen, Patrik A1 - Holm, Liisa A1 - Chen, Ching-Tai A1 - Hsu, Wen-Lian A1 - Bryson, Kevin A1 - Cozzetto, Domenico A1 - Minneci, Federico A1 - Jones, David T. A1 - Chapman, Samuel A1 - BKC, Dukka A1 - Khan, Ishita K. A1 - Kihara, Daisuke A1 - Ofer, Dan A1 - Rappoport, Nadav A1 - Stern, Amos A1 - Cibrian-Uhalte, Elena A1 - Denny, Paul A1 - Foulger, Rebecca E. A1 - Hieta, Reija A1 - Legge, Duncan A1 - Lovering, Ruth C. A1 - Magrane, Michele A1 - Melidoni, Anna N. A1 - Mutowo-Meullenet, Prudence A1 - Pichler, Klemens A1 - Shypitsyna, Aleksandra A1 - Li, Biao A1 - Zakeri, Pooya A1 - ElShal, Sarah A1 - Tranchevent, Léon-Charles A1 - Das, Sayoni A1 - Dawson, Natalie L. A1 - Lee, David A1 - Lees, Jonathan G. A1 - Sillitoe, Ian A1 - Bhat, Prajwal A1 - Nepusz, Tamás A1 - Romero, Alfonso E. A1 - Sasidharan, Rajkumar A1 - Yang, Haixuan A1 - Paccanaro, Alberto A1 - Gillis, Jesse A1 - Sedeño-Cortés, Adriana E. A1 - Pavlidis, Paul A1 - Feng, Shou A1 - Cejuela, Juan M. A1 - Goldberg, Tatyana A1 - Hamp, Tobias A1 - Richter, Lothar A1 - Salamov, Asaf A1 - Gabaldon, Toni A1 - Marcet-Houben, Marina A1 - Supek, Fran A1 - Gong, Qingtian A1 - Ning, Wei A1 - Zhou, Yuanpeng A1 - Tian, Weidong A1 - Falda, Marco A1 - Fontana, Paolo A1 - Lavezzo, Enrico A1 - Toppo, Stefano A1 - Ferrari, Carlo A1 - Giollo, Manuel A1 - Piovesan, Damiano A1 - Tosatto, Silvio C. E. A1 - del Pozo, Angela A1 - Fernández, José M. A1 - Maietta, Paolo A1 - Valencia, Alfonso A1 - Tress, Michael L. A1 - Benso, Alfredo A1 - Di Carlo, Stefano A1 - Politano, Gianfranco A1 - Savino, Alessandro A1 - Rehman, Hafeez Ur A1 - Re, Matteo A1 - Mesiti, Marco A1 - Valentini, Giorgio A1 - Bargsten, Joachim W. A1 - van Dijk, Aalt D. J. A1 - Gemovic, Branislava A1 - Glisic, Sanja A1 - Perovic, Vladmir A1 - Veljkovic, Veljko A1 - Almeida-e-Silva, Danillo C. A1 - Vencio, Ricardo Z. N. A1 - Sharan, Malvika A1 - Vogel, Jörg A1 - Kansakar, Lakesh A1 - Zhang, Shanshan A1 - Vucetic, Slobodan A1 - Wang, Zheng A1 - Sternberg, Michael J. E. A1 - Wass, Mark N. A1 - Huntley, Rachael P. A1 - Martin, Maria J. A1 - O'Donovan, Claire A1 - Robinson, Peter N. A1 - Moreau, Yves A1 - Tramontano, Anna A1 - Babbitt, Patricia C. A1 - Brenner, Steven E. A1 - Linial, Michal A1 - Orengo, Christine A. A1 - Rost, Burkhard A1 - Greene, Casey S. A1 - Mooney, Sean D. A1 - Friedberg, Iddo A1 - Radivojac, Predrag A1 - Veljkovic, Nevena T1 - An expanded evaluation of protein function prediction methods shows an improvement in accuracy JF - Genome Biology N2 - Background A major bottleneck in our understanding of the molecular underpinnings of life is the assignment of function to proteins. While molecular experiments provide the most reliable annotation of proteins, their relatively low throughput and restricted purview have led to an increasing role for computational function prediction. However, assessing methods for protein function prediction and tracking progress in the field remain challenging. Results We conducted the second critical assessment of functional annotation (CAFA), a timed challenge to assess computational methods that automatically assign protein function. We evaluated 126 methods from 56 research groups for their ability to predict biological functions using Gene Ontology and gene-disease associations using Human Phenotype Ontology on a set of 3681 proteins from 18 species. CAFA2 featured expanded analysis compared with CAFA1, with regards to data set size, variety, and assessment metrics. To review progress in the field, the analysis compared the best methods from CAFA1 to those of CAFA2. Conclusions The top-performing methods in CAFA2 outperformed those from CAFA1. This increased accuracy can be attributed to a combination of the growing number of experimental annotations and improved methods for function prediction. The assessment also revealed that the definition of top-performing algorithms is ontology specific, that different performance metrics can be used to probe the nature of accurate predictions, and the relative diversity of predictions in the biological process and human phenotype ontologies. While there was methodological improvement between CAFA1 and CAFA2, the interpretation of results and usefulness of individual methods remain context-dependent. KW - Protein function prediction KW - Disease gene prioritization Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-166293 VL - 17 IS - 184 ER - TY - JOUR A1 - Mühlberg, Eric A1 - Umstätter, Florian A1 - Domhan, Cornelius A1 - Hertlein, Tobias A1 - Ohlsen, Knut A1 - Krause, Andreas A1 - Kleist, Christian A1 - Beijer, Barbro A1 - Zimmermann, Stefan A1 - Haberkorn, Uwe A1 - Mier, Walter A1 - Uhl, Philipp T1 - Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci JF - Pharmaceuticals N2 - Multidrug-resistant bacteria represent one of the most important health care problems worldwide. While there are numerous drugs available for standard therapy, there are only a few compounds capable of serving as a last resort for severe infections. Therefore, approaches to control multidrug-resistant bacteria must be implemented. Here, a strategy of reactivating the established glycopeptide antibiotic vancomycin by structural modification with polycationic peptides and subsequent fatty acid conjugation to overcome the resistance of multidrug-resistant bacteria was followed. This study especially focuses on the structure–activity relationship, depending on the modification site and fatty acid chain length. The synthesized conjugates showed high antimicrobial potential on vancomycin-resistant enterococci. We were able to demonstrate that the antimicrobial activity of the vancomycin-lipopeptide conjugates depends on the chain length of the attached fatty acid. All conjugates showed good cytocompatibility in vitro and in vivo. Radiolabeling enabled the in vivo determination of pharmacokinetics in Wistar rats by molecular imaging and biodistribution studies. An improved biodistribution profile in comparison to unmodified vancomycin was observed. While vancomycin is rapidly excreted by the kidneys, the most potent conjugate shows a hepatobiliary excretion profile. In conclusion, these results demonstrate the potential of the structural modification of already established antibiotics to provide highly active compounds for tackling multidrug-resistant bacteria. KW - antibiotics KW - multidrug-resistant bacteria KW - enterococci KW - vancomycin KW - structural modification KW - fatty acids KW - polycationic peptides Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-205879 SN - 1424-8247 VL - 13 IS - 6 ER - TY - JOUR A1 - Kayisoglu, Özge A1 - Schlegel, Nicolas A1 - Bartfeld, Sina T1 - Gastrointestinal epithelial innate immunity-regionalization and organoids as new model JF - Journal of Molecular Medicine N2 - The human gastrointestinal tract is in constant contact with microbial stimuli. Its barriers have to ensure co-existence with the commensal bacteria, while enabling surveillance of intruding pathogens. At the centre of the interaction lies the epithelial layer, which marks the boundaries of the body. It is equipped with a multitude of different innate immune sensors, such as Toll-like receptors, to mount inflammatory responses to microbes. Dysfunction of this intricate system results in inflammation-associated pathologies, such as inflammatory bowel disease. However, the complexity of the cellular interactions, their molecular basis and their development remains poorly understood. In recent years, stem cell-derived organoids have gained increasing attention as promising models for both development and a broad range of pathologies, including infectious diseases. In addition, organoids enable the study of epithelial innate immunity in vitro. In this review, we focus on the gastrointestinal epithelial barrier and its regional organization to discuss innate immune sensing and development. KW - regionalization and organoids KW - immunity KW - gastrointestinal tract Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-265220 VL - 99 IS - 4 ER - TY - JOUR A1 - Okoro, Chinyere K. A1 - Barquist, Lars A1 - Connor, Thomas R. A1 - Harris, Simon R. A1 - Clare, Simon A1 - Stevens, Mark P. A1 - Arends, Mark J. A1 - Hale, Christine A1 - Kane, Leanne A1 - Pickard, Derek J. A1 - Hill, Jennifer A1 - Harcourt, Katherine A1 - Parkhill, Julian A1 - Dougan, Gordon A1 - Kingsley, Robert A. T1 - Signatures of adaptation in human invasive Salmonella Typhimurium ST313 populations from sub-Saharan Africa JF - PLoS Neglected Tropical Diseases N2 - Two lineages of Salmonella enterica serovar Typhimurium (S. Typhimurium) of multi-locus sequence type ST313 have been linked with the emergence of invasive Salmonella disease across sub-Saharan Africa. The expansion of these lineages has a temporal association with the HIV pandemic and antibiotic usage. We analysed the whole genome sequence of 129 ST313 isolates representative of the two lineages and found evidence of lineage-specific genome degradation, with some similarities to that observed in S. Typhi. Individual ST313 S. Typhimurium isolates exhibit a distinct metabolic signature and modified enteropathogenesis in both a murine and cattle model of colitis, compared to S. Typhimurium outside of the ST313 lineages. These data define phenotypes that distinguish ST313 isolates from other S. Typhimurium and may represent adaptation to a distinct pathogenesis and lifestyle linked to an-immuno-compromised human population. KW - genome sequence KW - infection KW - pathogenicity KW - children KW - disease KW - adults KW - identification KW - Escherichia coli KW - virulence Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-143779 VL - 9 IS - 3 ER - TY - JOUR A1 - Berg, Stefan A1 - Schelling, Esther A1 - Hailu, Elena A1 - Firdessa, Rebuma A1 - Gumi, Balako A1 - Erenso, Girume A1 - Gadisa, Endalamaw A1 - Mengistu, Araya A1 - Habtamu, Meseret A1 - Hussein, Jemal A1 - Kiros, Teklu A1 - Bekele, Shiferaw A1 - Mekonnen, Wondale A1 - Derese, Yohannes A1 - Zinsstag, Jakob A1 - Ameni, Gobena A1 - Gagneux, Sebastien A1 - Robertson, Brian D A1 - Tschopp, Rea A1 - Hewinson, Glyn A1 - Yamuah, Lawrence A1 - Gordon, Stephen V A1 - Aseffa, Abraham T1 - Investigation of the high rates of extrapulmonary tuberculosis in Ethiopia reveals no single driving factor and minimal evidence for zoonotic transmission of Mycobacterium bovis infection JF - BMC Infectious Diseases N2 - Background: Ethiopia, a high tuberculosis (TB) burden country, reports one of the highest incidence rates of extra-pulmonary TB dominated by cervical lymphadenitis (TBLN). Infection with Mycobacterium bovis has previously been excluded as the main reason for the high rate of extra-pulmonary TB in Ethiopia. Methods: Here we examined demographic and clinical characteristics of 953 pulmonary (PTB) and 1198 TBLN patients visiting 11 health facilities in distinct geographic areas of Ethiopia. Clinical characteristics were also correlated with genotypes of the causative agent, Mycobacterium tuberculosis. Results: No major patient or bacterial strain factor could be identified as being responsible for the high rate of TBLN, and there was no association with HIV infection. However, analysis of the demographic data of involved patients showed that having regular and direct contact with live animals was more associated with TBLN than with PTB, although no M. bovis was isolated from patients with TBLN. Among PTB patients, those infected with Lineage 4 reported "contact with other TB patient" more often than patients infected with Lineage 3 did (OR = 1.6, CI 95% 1.0-2.7; p = 0.064). High fever, in contrast to low and moderate fever, was significantly associated with Lineage 4 (OR = 2.3; p = 0.024). On the other hand, TBLN cases infected with Lineage 4 tended to get milder symptoms overall for the constitutional symptoms than those infected with Lineage 3. Conclusions: The study suggests a complex role for multiple interacting factors in the epidemiology of extra-pulmonary TB in Ethiopia, including factors that can only be derived from population-based studies, which may prove to be significant for TB control in Ethiopia. KW - zoonotic KW - Mycobacterium KW - Ethiopia KW - tuberculosis KW - Bovis KW - pulmonary KW - extrapulmonary KW - lymphadenitis Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-143935 VL - 15 IS - 112 ER - TY - THES A1 - Reuter-Weissenberger, Philipp T1 - The role of a fungal-specific transcription regulator on vacuolar biology and host interaction in \(Candida\) \(albicans\) T1 - Die Rolle eines pilzspezifischen Transkriptionsfaktors für die Vakuole und Wirtsinteraktion von \(Candida\) \(albicans\) N2 - Microorganisms that colonize the human body face large fluctuations in their surroundings. Therefore, those microbes developed sophisticated mechanisms that allow them to adapt their cell biology and maintain cellular homeostasis. One organelle vital to preserve cell physiology is the vacuole. The vacuole exhibits a wide range of functions and is able to adjust itself in response to both external and internal stimuli. Moreover, it plays an important role in host interaction and virulence in fungi such as Candida albicans. Despite this connection, only a few regulatory proteins have been described to modulate vacuolar biology in fungal pathogens. Furthermore, whether such regulation alters fungus-host interplay remains largely unknown. This thesis focuses on the characterization of ZCF8, a fungus-specific transcription regulator in the human-associated yeast C. albicans. To this end, I combined genome-wide protein-DNA interaction assays and gene expression analysis that identified genes regulated by Zcf8p. Fluorescence microscopy uncovered that several top targets of Zcf8p localize to the fungal vacuole. Moreover, deletion and overexpression of ZCF8 resulted in alterations in vacuolar morphology and in luminal pH and rendered the fungus resistant or susceptible to a vacuole-disturbing drug. Finally, in vitro adherence assays showed that Zcf8p modulates the attachment of C. albicans to human epithelial cells in a vacuole-dependent manner. Given those findings, I posit that the previously uncharacterized transcription regulator Zcf8p modulates fungal attachment to epithelial cells in a manner that depends on the status of the fungal vacuole. Furthermore, the results highlight that vacuolar physiology is a substantial factor influencing the physical interaction between Candida cells and mammalian mucosal surfaces. N2 - Mikroorganismen, die den Menschen besiedeln, sind großen Schwankungen in ihrer Umgebung ausgesetzt. Daher haben sie ausgeklügelte Mechanismen entwickelt, die es ihnen ermöglichen, ihre Zellbiologie anzupassen und die zelluläre Homöostase aufrechtzuerhalten. Eine für die Aufrechterhaltung der Zellphysiologie wichtige Organelle ist die Vakuole. Sie verfügt über ein breites Spektrum an Funktionen und ist in der Lage, auf externe und interne Stimuli zu reagieren. Außerdem spielt dieses Organell eine wichtige Rolle bei der Pilz-Wirt-Interaktion und somit für die Pathogenität von Pilzen wie Candida albicans. Trotz dieses Zusammenhangs wurden bisher nur wenige regulatorische Proteine beschrieben, welche die Biologie der Vakuolen in pathogenen Pilzen modulieren. Zudem ist weitgehend unbekannt, ob eine solche Regulierung das Zusammenspiel von Pilz und Wirt verändert. Diese Arbeit konzentriert sich auf die Charakterisierung von ZCF8, einem pilzspezifischen Transkriptionsregulator in der pathogenen Hefe C. albicans. Zu diesem Zweck wurden Protein-DNA-Interaktionstests und Genexpressionsanalysen kombiniert, um Gene zu identifizieren, die direkt von Zcf8p reguliert werden. Fluoreszenzmikroskopie zeigte zudem, dass mehrere der wichtigsten Ziele von Zcf8p in der Pilzvakuole lokalisiert sind. Darüber hinaus führte die Deletion und Überexpression von ZCF8 zu Veränderungen der Morphologie und des luminalen pH-Werts der Vakuole, und veränderte die Sensitivität des Pilzes gegenüber Stoffen, welche Funktionen der Vakuole beeinträchtigen. Schließlich deuteten In-vitro-Adhärenztests daraufhin, dass Zcf8p die Anheftung von C. albicans an menschliche Epithelzellen auf eine Weise moduliert, die abhängig von der Vakuole ist. Angesichts dieser Ergebnisse kann davon ausgegangen werden, dass der bisher unbekannte Transkriptionsregulator ZCF8 die Interaktion zwischen Pilz- und Epithelzellen des Wirts kontrolliert, und das auf eine Weise, die von der Pilzvakuole abhängig ist. Des Weiteren, unterstreichen die Ergebnisse, dass die Physiologie der Vakuole ein wesentlicher Faktor ist, welcher die Interaktion zwischen C. albicans und dem Wirt beeinflusst. KW - Vakuole KW - Transkriptionsfaktor KW - Candida albicans KW - vacuole KW - host colonization KW - Candida albicans KW - transcription regulator Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259287 ER - TY - JOUR A1 - Marincola, Gabriella A1 - Liong, Olivia A1 - Schoen, Christoph A1 - Abouelfetouh, Alaa A1 - Hamdy, Aisha A1 - Wencker, Freya D. R. A1 - Marciniak, Tessa A1 - Becker, Karsten A1 - Köck, Robin A1 - Ziebuhr, Wilma T1 - Antimicrobial Resistance Profiles of Coagulase-Negative Staphylococci in Community-Based Healthy Individuals in Germany JF - Frontiers in Public Health N2 - Coagulase-negative staphylococci (CoNS) are common opportunistic pathogens, but also ubiquitous human and animal commensals. Infection-associated CoNS from healthcare environments are typically characterized by pronounced antimicrobial resistance (AMR) including both methicillin- and multidrug-resistant isolates. Less is known about AMR patterns of CoNS colonizing the general population. Here we report on AMR in commensal CoNS recovered from 117 non-hospitalized volunteers in a region of Germany with a high livestock density. Among the 69 individuals colonized with CoNS, 29 had reported contacts to either companion or farm animals. CoNS were selectively cultivated from nasal swabs, followed by species definition by 16S rDNA sequencing and routine antibiotic susceptibility testing. Isolates displaying phenotypic AMR were further tested by PCR for presence of selected AMR genes. A total of 127 CoNS were isolated and Staphylococcus epidermidis (75%) was the most common CoNS species identified. Nine isolates (7%) were methicillin-resistant (MR) and carried the mecA gene, with seven individuals (10%) being colonized with at least one MR-CoNS isolate. While resistance against gentamicin, phenicols and spectinomycin was rare, high resistance rates were found against tetracycline (39%), erythromycin (33%) and fusidic acid (24%). In the majority of isolates, phenotypic resistance could be associated with corresponding AMR gene detection. Multidrug-resistance (MDR) was observed in 23% (29/127) of the isolates, with 33% (23/69) of the individuals being colonized with MDR-CoNS. The combined data suggest that MR- and MDR-CoNS are present in the community, with previous animal contact not significantly influencing the risk of becoming colonized with such isolates. KW - coagulase-negative staphylococci KW - antimicrobial resistance KW - One Health KW - community settings KW - Germany Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-240881 SN - 2296-2565 VL - 9 ER - TY - THES A1 - Sharan, Malvika T1 - Bio-computational identification and characterization of RNA-binding proteins in bacteria T1 - Bioinformatische Identifikation und Charakterisierung von RNA-bindenden Proteinen in Bakterien N2 - RNA-binding proteins (RBPs) have been extensively studied in eukaryotes, where they post-transcriptionally regulate many cellular events including RNA transport, translation, and stability. Experimental techniques, such as cross-linking and co-purification followed by either mass spectrometry or RNA sequencing has enabled the identification and characterization of RBPs, their conserved RNA-binding domains (RBDs), and the regulatory roles of these proteins on a genome-wide scale. These developments in quantitative, high-resolution, and high-throughput screening techniques have greatly expanded our understanding of RBPs in human and yeast cells. In contrast, our knowledge of number and potential diversity of RBPs in bacteria is comparatively poor, in part due to the technical challenges associated with existing global screening approaches developed in eukaryotes. Genome- and proteome-wide screening approaches performed in silico may circumvent these technical issues to obtain a broad picture of the RNA interactome of bacteria and identify strong RBP candidates for more detailed experimental study. Here, I report APRICOT (“Analyzing Protein RNA Interaction by Combined Output Technique”), a computational pipeline for the sequence-based identification and characterization of candidate RNA-binding proteins encoded in the genomes of all domains of life using RBDs known from experimental studies. The pipeline identifies functional motifs in protein sequences of an input proteome using position-specific scoring matrices and hidden Markov models of all conserved domains available in the databases and then statistically score them based on a series of sequence-based features. Subsequently, APRICOT identifies putative RBPs and characterizes them according to functionally relevant structural properties. APRICOT performed better than other existing tools for the sequence-based prediction on the known RBP data sets. The applications and adaptability of the software was demonstrated on several large bacterial RBP data sets including the complete proteome of Salmonella Typhimurium strain SL1344. APRICOT reported 1068 Salmonella proteins as RBP candidates, which were subsequently categorized using the RBDs that have been reported in both eukaryotic and bacterial proteins. A set of 131 strong RBP candidates was selected for experimental confirmation and characterization of RNA-binding activity using RNA co-immunoprecipitation followed by high-throughput sequencing (RIP-Seq) experiments. Based on the relative abundance of transcripts across the RIP-Seq libraries, a catalogue of enriched genes was established for each candidate, which shows the RNA-binding potential of 90% of these proteins. Furthermore, the direct targets of few of these putative RBPs were validated by means of cross-linking and co-immunoprecipitation (CLIP) experiments. This thesis presents the computational pipeline APRICOT for the global screening of protein primary sequences for potential RBPs in bacteria using RBD information from all kingdoms of life. Furthermore, it provides the first bio-computational resource of putative RBPs in Salmonella, which could now be further studied for their biological and regulatory roles. The command line tool and its documentation are available at https://malvikasharan.github.io/APRICOT/. N2 - RNA-bindende Proteine (RBPs) wurden umfangreich in Eukaryoten erforscht, in denen sie viele Prozesse wie RNA-Transport, -Translation und -Stabilität post-transkriptionell regulieren. Experimentelle Methoden wie Cross-linking and Koimmunpräzipitation mit nachfolgedener Massenspektromentrie / RNA-Sequenzierung ermöglichten eine weitreichende Charakterisierung von RBPs, RNA-bindenden Domänen (RBDs) und deren regulatorischen Rollen in eukaryotischen Spezies wie Mensch und Hefe. Weitere Entwicklungen im Bereich der hochdurchsatzbasierten Screeningverfahren konnten das Verständnis von RBPs in Eukaryoten enorm erweitern. Im Gegensatz dazu ist das Wissen über die Anzahl und die potenzielle Vielfalt von RBPs in Bakterien dürftig. In der vorliegenden Arbeit präsentiere ich APRICOT, eine bioinformatische Pipeline zur sequenzbasierten Identifikation und Charakterisierung von Proteinen aller Domänen des Lebens, die auf RBD-Informationen aus experimentellen Studien aufbaut. Die Pipeline nutzt Position Specific Scoring Matrices und Hidden-MarkovModelle konservierter Domänen, um funktionelle Motive in Proteinsequenzen zu identifizieren und diese anhand von sequenzbasierter Eigenschaften statistisch zu bewerten. Anschließend identifiziert APRICOT mögliche RBPs und charakterisiert auf Basis ihrer biologischeren Eigenschaften. In Vergleichen mit ähnlichen Werkzeugen übertraf APRICOT andere Programme zur sequenzbasierten Vorhersage von RBPs. Die Anwendungsöglichkeiten und die Flexibilität der Software wird am Beispiel einiger großer RBP-Kollektionen, die auch das komplette Proteom von Salmonella Typhimurium SL1344 beinhalten, dargelegt. APRICOT identifiziert 1068 Proteine von Salmonella als RBP-Kandidaten, die anschließend unter Nutzung der bereits bekannten bakteriellen und eukaryotischen RBDs klassifiziert wurden. 131 der RBP-Kandidaten wurden zur Charakterisierung durch RNA co-immunoprecipitation followed by high-throughput sequencing (RIP-seq) ausgewählt. Basierend auf der relativen Menge an Transkripten in den RIP-seq-Bibliotheken wurde ein Katalog von angereicherten Genen erstellt, der auf eine potentielle RNA-bindende Funktion in 90% dieser Proteine hindeutet. Weiterhin wurden die Bindungstellen einiger dieser möglichen RBPs mit Cross-linking and Co-immunoprecipitation (CLIP) bestimmt. Diese Doktorarbeit beschreibt die bioinformatische Pipeline APRICOT, die ein globales Screening von RBPs in Bakterien anhand von Informationen bekannter RBDs ermöglicht. Zudem enthält sie eine Zusammenstellung aller potentieller RPS in Salmonella, die nun auf ihre biologsche Funktion hin untersucht werden können. Das Kommondozeilen-Programm und seine Dokumentation sind auf https://malvikasharan.github.io/APRICOT/ verfügbar. KW - Bioinformatics Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-153573 ER - TY - JOUR A1 - Liang, Chunguang A1 - Rios-Miguel, Ana B. A1 - Jarick, Marcel A1 - Neurgaonkar, Priya A1 - Girard, Myriam A1 - François, Patrice A1 - Schrenzel, Jacques A1 - Ibrahim, Eslam S. A1 - Ohlsen, Knut A1 - Dandekar, Thomas T1 - Staphylococcus aureus transcriptome data and metabolic modelling investigate the interplay of Ser/Thr kinase PknB, its phosphatase Stp, the glmR/yvcK regulon and the cdaA operon for metabolic adaptation JF - Microorganisms N2 - Serine/threonine kinase PknB and its corresponding phosphatase Stp are important regulators of many cell functions in the pathogen S. aureus. Genome-scale gene expression data of S. aureus strain NewHG (sigB\(^+\)) elucidated their effect on physiological functions. Moreover, metabolic modelling from these data inferred metabolic adaptations. We compared wild-type to deletion strains lacking pknB, stp or both. Ser/Thr phosphorylation of target proteins by PknB switched amino acid catabolism off and gluconeogenesis on to provide the cell with sufficient components. We revealed a significant impact of PknB and Stp on peptidoglycan, nucleotide and aromatic amino acid synthesis, as well as catabolism involving aspartate transaminase. Moreover, pyrimidine synthesis was dramatically impaired by stp deletion but only slightly by functional loss of PknB. In double knockouts, higher activity concerned genes involved in peptidoglycan, purine and aromatic amino acid synthesis from glucose but lower activity of pyrimidine synthesis from glucose compared to the wild type. A second transcriptome dataset from S. aureus NCTC 8325 (sigB\(^−\)) validated the predictions. For this metabolic adaptation, PknB was found to interact with CdaA and the yvcK/glmR regulon. The involved GlmR structure and the GlmS riboswitch were modelled. Furthermore, PknB phosphorylation lowered the expression of many virulence factors, and the study shed light on S. aureus infection processes. KW - metabolism KW - flux balance analysis KW - phosphorylation KW - regulation KW - riboswitch KW - PknB KW - Stp KW - yvcK/glmR operon Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-248459 SN - 2076-2607 VL - 9 IS - 10 ER - TY - THES A1 - Alzheimer, Mona T1 - Development of tissue-engineered three-dimensional infection models to study pathogenesis of \(Campylobacter\) \(jejuni\) T1 - Entwicklung dreidimensionaler Infektionsmodelle basierend auf Gewebezüchtung zur Erforschung der Pathogenese von \(Campylobacter\) \(jejuni\) N2 - Infectious diseases caused by pathogenic microorganisms are one of the largest socioeconomic burdens today. Although infectious diseases have been studied for decades, in numerous cases, the precise mechanisms involved in the multifaceted interaction between pathogen and host continue to be elusive. Thus, it still remains a challenge for researchers worldwide to develop novel strategies to investigate the molecular context of infectious diseases in order to devise preventive or at least anti-infective measures. One of the major drawbacks in trying to obtain in-depth knowledge of how bacterial pathogens elicit disease is the lack of suitable infection models to authentically mimic the disease progression in humans. Numerous studies rely on animal models to emulate the complex temporal interactions between host and pathogen occurring in humans. While they have greatly contributed to shed light on these interactions, they require high maintenance costs, are afflicted with ethical drawbacks, and are not always predictive for the infection outcome in human patients. Alternatively, in-vitro two-dimensional (2D) cell culture systems have served for decades as representatives of human host environments to study infectious diseases. These cell line-based models have been essential in uncovering virulence-determining factors of diverse pathogens as well as host defense mechanisms upon infection. However, they lack the morphological and cellular complexity of intact human tissues, limiting the insights than can be gained from studying host-pathogen interactions in these systems. The focus of this thesis was to establish and innovate intestinal human cell culture models to obtain in-vitro reconstructed three-dimensional (3D) tissue that can faithfully mimic pathogenesis-determining processes of the zoonotic bacterium Campylobacter jejuni (C. jejuni). Generally employed for reconstructive medicine, the field of tissue engineering provides excellent tools to generate organ-specific cell culture models in vitro, realistically recapitulating the distinctive architecture of human tissues. The models employed in this thesis are based on decellularized extracellular matrix (ECM) scaffolds of porcine intestinal origin. Reseeded with intestinal human cells, application of dynamic culture conditions promoted the formation of a highly polarized mucosal epithelium maintained by functional tight and adherens junctions. While most other in-vitro infection systems are limited to a flat monolayer, the tissue models developed in this thesis can display the characteristic 3D villi and crypt structure of human small intestine. First, experimental conditions were established for infection of a previously developed, statically cultivated intestinal tissue model with C. jejuni. This included successful isolation of bacterial colony forming units (CFUs), measurement of epithelial barrier function, as well as immunohistochemical and histological staining techniques. In this way, it became possible to follow the number of viable bacteria during the infection process as well as their translocation over the polarized epithelium of the tissue model. Upon infection with C. jejuni, disruption of tight and adherens junctions could be observed via confocal microscopy and permeability measurements of the epithelial barrier. Moreover, C. jejuni wildtype-specific colonization and barrier disruption became apparent in addition to niche-dependent bacterial localization within the 3D microarchitecture of the tissue model. Pathogenesis-related phenotypes of C. jejuni mutant strains in the 3D host environment deviated from those obtained with conventional in-vitro 2D monolayers but mimicked observations made in vivo. Furthermore, a genome-wide screen of a C. jejuni mutant library revealed significant differences for bacterial factors required or dispensable for interactions with unpolarized host cells or the highly prismatic epithelium provided by the intestinal tissue model. Elucidating the role of several previously uncharacterized factors specifically important for efficient colonization of a 3D human environment, promises to be an intriguing task for future research. At the frontline of the defense against invading pathogens is the protective, viscoelastic mucus layer overlying mucosal surfaces along the human gastrointestinal tract (GIT). The development of a mucus-producing 3D tissue model in this thesis was a vital step towards gaining a deeper understanding of the interdependency between bacterial pathogens and host-site specific mucins. The presence of a mucus layer conferred C. jejuni wildtype-specific protection against epithelial barrier disruption by the pathogen and prevented a high bacterial burden during the course of infection. Moreover, results obtained in this thesis provide evidence in vitro that the characteristic corkscrew morphology of C. jejuni indeed grants a distinct advantage in colonizing mucous surfaces. Overall, the results obtained within this thesis highlight the strength of the tissue models to combine crucial features of native human intestine into accessible in-vitro infection models. Translation of these systems into infection research demonstrated their ability to expose in-vivo like infection outcomes. While displaying complex organotypic architecture and highly prismatic cellular morphology, these tissue models still represent an imperfect reflection of human tissue. Future advancements towards inclusion of human primary and immune cells will strive for even more comprehensive model systems exhibiting intricate multicellular networks of in-vivo tissue. Nevertheless, the work presented in this thesis emphasizes the necessity to investigate host-pathogen interactions in infection models authentically mimicking the natural host environment, as they remain among the most vital parts in understanding and counteracting infectious diseases. N2 - In der heutigen Zeit tragen insbesondere durch pathogene Mikroorganismen ausgelöste Infektionskrankheiten zur sozioökonomischen Belastung bei. Obwohl bereits jahrzehntelang an der Entstehung von Infektionskrankheiten geforscht wird, bleiben in zahlreichen Fällen die genauen Mechanismen, welche an den vielfältigen Interaktionen zwischen Pathogen und Wirt beteiligt sind, unbeschrieben. Gerade deshalb bleibt es für Wissenschaftler weltweit eine Herausforderung, neue Strategien zur Untersuchung des molekularen Kontexts von Infektionskrankheiten zu entwickeln, um präventive oder zumindest anti-infektive Maßnahmen ergreifen zu können. In den meisten Fällen ist jedoch das Fehlen geeigneter Infektionsmodelle, mit denen der Krankheitsverlauf im Menschen authentisch nachgestellt werden kann, eines der größten Hindernisse um detailliertes Wissen darüber gewinnen zu können wie bakterielle Pathogene die Krankheit auslösen. Zahlreiche Studien sind dabei auf Tiermodelle angewiesen, um die komplexen zeitlichen Abläufe zwischen Wirt und Pathogen im menschlichen Körper nachzuahmen. Während diese Modelle in hohem Maß dazu beigetragen haben, Aufschluss über diese Abläufe zu geben, sind sie doch sehr kostenintensiv, mit ethischen Bedenken behaftet und können nicht immer die Folgen einer Infektion im menschlichen Patienten vorhersagen. Seit Jahrzehnten werden daher alternativ in-vitro 2D Zellkultursysteme eingesetzt, um den Verlauf von Infektionskrankheiten zu erforschen, welche die Bedingungen im menschlichen Wirt wiederspiegeln sollen. Diese auf Zelllinien basierenden Modelle sind essentiell in der Entdeckung von Virulenzfaktoren diverser Pathogene, aber auch in der Aufklärung von wirtsspezifischen Abwehrmechanismen. Dennoch fehlt ihnen die morphologische und zelluläre Komplexität von intaktem menschlichen Gewebe. Dadurch sind die Erkenntnisse, die mit diesen Systemen über Infektionsverläufe gewonnen werden können, limitiert. Die vorgelegte Arbeit konzentriert sich auf die Etablierung und Weiterentwicklung intestinaler, humaner Zellkulturmodelle, um dreidimensionales Gewebe in vitro zu rekonstruieren mit dem Ziel, Pathogenese-beeinflussende Prozesse des zoonotischen Bakteriums C. jejuni nachzustellen. Das Fachgebiet der Gewebezüchtung wird üblicherweise für rekonstruktive Medizin eingesetzt und bietet exzellente Mittel zur in-vitro Herstellung organspezifischer Zellkulturmodelle, welche die unverkennbare Mikroarchitektur humanen Gewebes realistisch nachempfinden können. Die in dieser Arbeit verwendeten Modelle basieren auf einem extrazellulären Matrixgerüst, das aus der Dezellularisierung von Schweinedarm gewonnen wurde. Durch die Wiederbesiedelung mit human Kolonzellen und der Kultivierung unter dynamischen Bedingungen entwickelte sich ein hochpolarisiertes mucosales Epithel, das durch funktionale Zell-Zell-Kontakte (tight und adherens junctions) aufrechterhalten wird. Während andere in-vitro Infektionssysteme meist durch die Präsenz einer flachen Zellschicht limitiert werden, entwickelt das in dieser Arbeit eingeführte Gewebemodell die für den menschlichen Dünndarm charakteristische Architektur aus Villi und Krypten. Zunächst wurden experimentelle Bedingungen für die Infektion eines zuvor entwickelten, statisch kultivierten Dünndarmmodells mit C. jejuni etabliert. Dies beinhaltete die erfolgreiche Isolierung koloniebildender Einheiten, die Messung der epithelialen Barrierefunktion, sowie immunhistochemische und histologische Färbetechniken. Dadurch konnte die Anzahl der Bakterien sowie deren Translokalisierung über das polarisierte Epithel während des Infektionsprozesses nachvollzogen werden. Außerdem konnte die Beeinträchtigung von Zell-Zell-Kontakten durch konfokale Mikroskopie und Permeabilitätsmessungen der epithelialen Barriere beobachtet werden. Neben der Bestimmung der Kolonisierungsrate von C. jejuni Isolaten und der dadurch hervorgerufenen spezifischen Zerstörung der epithelialen Barriere konnten die Bakterien auch innerhalb der 3D Mikroarchitektur des Gewebemodells lokalisiert werden. Außerdem konnte im Rahmen der 3D Gewebeumgebung beobachtet werden, dass Pathogenese-relevante Phänotypen von C. jejuni Mutantenstämmen im Vergleich zu konventionellen in-vitro 2D Zellschichten abwichen, diese aber dafür mit den in-vivo gemachten Beobachtungen übereinstimmten. Darüber hinaus wies die genomweite Suche einer C. jejuni Mutantenbibliothek signifikante Unterschiede zwischen bakteriellen Faktoren, die für die Interaktion mit nicht polarisierten Wirtszellen oder dem hochprismatischen Epithel des Gewebemodells bedeutsam oder entbehrlich waren, auf. Die Aufklärung der Funktion einiger bisher nicht charakterisierter Faktoren, die zu einer effizienten Kolonisierung menschlichen Gewebes beitragen, verspricht eine faszinierende Aufgabe für die zukünftige Forschung zu werden. Die vorderste Verteidigungslinie gegen eindringende Pathogene bildet die schützende, viskoelastische Mukusschicht, die mukosale Oberflächen entlang des menschlichen Gastrointestinaltrakts überzieht. Mit der Entwicklung eines mukusproduzierenden Gewebemodells in der hier vorgelegten Arbeit gelang ein entscheidender Schritt zur Erforschung der Wechselbeziehungen zwischen bakteriellen Pathogenen und wirtsspezifischen Muzinen. Während des Infektionsverlaufs wurde das unterliegende Epithel durch die Anwesenheit der Mukusschicht vor der Zerstörung durch die Mikroben geschützt und eine erhöhte bakterielle Belastung verhindert. Darüber hinaus liefern die Resultate dieser Arbeit einen in-vitro Nachweis für den bakteriellen Vorteil einer spiralförmigen Morphologie, um muköse Oberflächen zu besiedeln. Zusammenfassend unterstreicht diese Arbeit das Potential der hier entwickelten Gewebemodelle, entscheidende Eigenschaften des menschlichen Darms in einem leicht zugänglichen in-vitro Infektionsmodell zu vereinigen. Der Einsatz dieser Modelle im Rahmen der Infektionsforschung bewies deren Fähigkeit in-vivo beobachtete Infektionsverläufe widerzuspiegeln. Während diese Infektionsmodelle bereits organotypische Architektur und hochprismatische Zellmorphologie aufweisen, ist ihre Darstellung von menschlichem Gewebe noch nicht perfekt. Durch den Einsatz von humanen Primär- und Immunzellen wird es in Zukunft möglich sein, noch umfassendere Modellsysteme zu entwickeln, die komplexe multizelluläre Netzwerke von in-vivo Geweben aufweisen. Nichtsdestotrotz verdeutlicht die hier vorgelegte Arbeit wie wichtig es ist, die Interaktionen zwischen Wirt und Pathogen innerhalb von Infektionsmodellen zu erforschen, welche die natürliche Wirtsumgebung wiedergeben. Dies spielt eine entscheidende Rolle, um die Entstehung von Infektionskrankheiten nachvollziehen und ihnen entgegenwirken zu können. KW - Campylobacter jejuni KW - Tissue Engineering KW - Small RNA KW - 3D tissue model KW - Bacterial infection KW - 3D Gewebemodelle KW - Bakterielle Infektion KW - 3D cell culture KW - Infection models Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-193440 ER - TY - THES A1 - Masota, Nelson Enos T1 - The Search for Novel Effective Agents Against Multidrug-Resistant Enterobacteriaceae T1 - Die Suche nach neuen wirksamen Wirkstoffen gegen multiresistente Enterobacteriaceae N2 - This thesis aimed at searching for new effective agents against Multidrug-Resistant Enterobacteriaceae. This is necessitated by the urgent need for new and innovative antibacterial agents addressing the critical priority pathogens prescribed by the World Health Organization (WHO). Among the available means for antibiotics discovery and development, nature has long remained a proven, innovative, and highly reliable gateway to successful antibacterial agents. Nevertheless, numerous challenges surrounding this valuable source of antibiotics among other drugs are limiting the complete realization of its potential. These include the availability of good quality data on the highly potential natural sources, limitations in methods to prepare and screen crude extracts, bottlenecks in reproducing biological potentials observed in natural sources, as well as hurdles in isolation, purification, and characterization of natural compounds with diverse structural complexities. Through an extensive review of the literature, it was possible to prepare libraries of plant species and phytochemicals with reported high potentials against Escherichia coli and Klebsiella pneumnoniae. The libraries were profiled to highlight the existing patterns and relationships between the reported antibacterial activities and studied plants’ families and parts, the type of the extracting solvent, as well as phytochemicals’ classes, drug-likeness and selected parameters for enhanced accumulation within the Gram-negative bacteria. In addition, motivations, objectives, the role of traditional practices and other crucial experimental aspects in the screening of plant extracts for antibacterial activities were identified and discussed. Based on the implemented strict inclusion criteria, the created libraries grant speedy access to well-evaluated plant species and phytochemicals with potential antibacterial activities. This way, further studies in yet unexplored directions can be pursued from the indicated or related species and compounds. Moreover, the availability of compound libraries focusing on related bacterial species serves a great role in the ongoing efforts to develop the rules of antibiotics penetrability and accumulation, particularly among Gram-negative bacteria. Here, in addition to hunting for potential scaffolds from such libraries, detailed evaluations of large pool compounds with related antibacterial potential can grant a better understanding of structural features crucial for their penetration and accumulation. Based on the scarcity of compounds with broad structural diversity and activity against Gram-negative bacteria, the creation and updating of such libraries remain a laborious but important undertaking. A Pressurized Microwave Assisted Extraction (PMAE) method over a short duration and low-temperature conditions was developed and compared to the conventional cold maceration over a prolonged duration. This method aimed at addressing the key challenges associated with conventional extraction methods which require long extraction durations, and use more energy and solvents, in addition to larger quantities of plant materials. Furthermore, the method was intended to replace the common use of high temperatures in most of the current MAE applications. Interestingly, the yields of 16 of 18 plant samples under PMAE over 30 minutes were found to be within 91–139% of those obtained from the 24h extraction by maceration. Additionally, different levels of selectivity were observed upon an analytical comparison of the extracts obtained from the two methods. Although each method indicated selective extraction of higher quantities or additional types of certain phytochemicals, a slightly larger number of additional compounds were observed under maceration. The use of this method allows efficient extraction of a large number of samples while sparing heat-sensitive compounds and minimizing chances for cross-reactions between phytochemicals. Moreover, findings from another investigation highlighted the low likelihood of reproducing antibacterial activities previously reported among various plant species, identified the key drivers of poor reproducibility, and proposed possible measures to mitigate the challenge. The majority of extracts showed no activities up to the highest tested concentration of 1024 µg/mL. In the case of identical plant species, some activities were observed only in 15% of the extracts, in which the Minimum Inhibitory Concentrations (MICs) were 4 – 16-fold higher than those in previous reports. Evaluation of related plant species indicated better outcomes, whereby about 18% of the extracts showed activities in a range of 128–512 μg/mL, some of the activities being superior to those previously reported in related species. Furthermore, solubilizing plant crude extracts during the preparation of test solutions for Antibacterial Susceptibility Testing (AST) assays was outlined as a key challenge. In trying to address this challenge, some studies have used bacteria-toxic solvents or generally unacceptable concentrations of common solubilizing agents. Both approaches are liable to give false positive results. In line with this challenge, this study has underscored the suitability of acetone in the solubilization of crude plant extracts. Using acetone, better solubility profiles of crude plant extracts were observed compared to dimethyl sulfoxide (DMSO) at up to 10 %v/v. Based on lacking toxicity against many bacteria species at up to 25 %v/v, its use in the solubilization of poorly water-soluble extracts, particularly those from less polar solvents is advocated. In a subsequent study, four galloylglucoses were isolated from the leaves of Paeonia officinalis L., whereby the isolation of three of them from this source was reported for the first time. The isolation and characterization of these compounds were driven by the crucial need to continually fill the pre-clinical antibiotics pipeline using all available means. Application of the bioautography-guided isolation and a matrix of extractive, chromatographic, spectroscopic, and spectrometric techniques enabled the isolation of the compounds at high purity levels and the ascertainment of their chemical structures. Further, the compounds exhibited the Minimum Inhibitory Concentrations (MIC) in a range of 2–256 µg/mL against Multidrug-Resistant (MDR) strains of E. coli and K. pneumonia exhibiting diverse MDR phenotypes. In that, the antibacterial activities of three of the isolated compounds were reported for the first time. The observed in vitro activities of the compounds resonated with their in vivo potentials as determined using the Galleria mellonella larvae model. Additionally, the susceptibility of the MDR bacteria to the galloylglucoses was noted to vary depending on the nature of the resistance enzymes expressed by the MDR bacteria. In that, the bacteria expressing enzymes with higher content of aromatic amino acids and zero or positive net charges were generally more susceptible. Following these findings, a plausible hypothesis for the observed patterns was put forward. The generally challenging pharmacokinetic properties of galloylglucoses limit their further development into therapeutic agents. However, the compounds can replace or reduce the use of antibiotics in livestock keeping as well as in the treatment of septic wounds and topical or oral cavity infections, among other potential uses. Using nature-inspired approaches, a series of glucovanillin derivatives were prepared following feasible synthetic pathways which in most cases ensured good yields and high purity levels. Some of the prepared compounds showed MIC values in a range of 128 – 512 μg/mL against susceptible and MDR strains of Klebsiella pneumoniae, Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus faecium (VRE). These findings emphasize the previously reported essence of small molecular size, the presence of protonatable amino groups and halogen atoms, as well as an amphiphilic character, as crucial features for potential antibacterial agents. Due to the experienced limited success in the search for new antibacterial agents using purely synthetic means, pursuing semi-synthetic approaches as employed in this study are highly encouraged. This way, it is possible to explore broader chemical spaces around natural scaffolds while addressing their inherent limitations such as solubility, toxicity, and poor pharmacokinetic profiles. N2 - Ziel dieser Arbeit war die Suche nach neuen wirksamen Antiinfektiva gegen multiresistente Enterobacteriaceae. Grund dafür ist der dringende Bedarf an neuen und innovativen antibakteriellen Wirkstoffen gegen die von der Weltgesundheitsorganisation (WHO) als vorrangig eingestuften Krankheitserreger. Unter den verfügbaren Methoden zur Entdeckung und Entwicklung von Antibiotika ist die Natur seit langem ein bewährtes, innovatives und äußerst zuverlässiges Mittel, um erfolgreich zu antibakteriellen Wirkstoffen zu gelangen. Dennoch stehen dieser wertvollen Quelle von Antibiotika und anderen Arzneimitteln zahlreiche Herausforderungen gegenüber, die die vollständige Ausschöpfung ihres Potenzials einschränken. Dazu gehören die Verfügbarkeit qualitativ hochwertiger Daten über die hochpotenten natürlichen Quellen, Einschränkungen bei den Methoden zur Herstellung und zum Screening von Rohextrakten, Engpässe bei der Reproduktion des in natürlichen Quellen beobachteten biologischen Potenzials sowie Hürden bei der Isolierung, Reinigung und Charakterisierung von Naturstoffen mit unterschiedlicher struktureller Komplexität. Mittels einer umfassenden Durchsicht der Literatur war es möglich, Bibliotheken mit Pflanzenarten und Phytochemikalien zu erstellen, die ein hohes Potenzial gegen Escherichia coli und Klebsiella pneumnonia aufweisen. Die Bibliotheken wurden profiliert, um die bestehenden Muster und Beziehungen zwischen den berichteten antibakteriellen Aktivitäten und den untersuchten Pflanzenfamilien und -teilen, der Art des Extraktionslösungsmittels sowie den Klassen der Phytochemikalien, der Wirkstoffähnlichkeit und ausgewählten Parametern für eine verstärkte Akkumulation in den gramnegativen Bakterien aufzuzeigen. Darüber hinaus wurden Motivationen, Ziele, die Rolle traditioneller Methoden und andere wichtige experimentelle Aspekte beim Screening von Pflanzenextrakten auf antibakterielle Aktivitäten identifiziert und diskutiert. Auf der Grundlage der strengen Aufnahmekriterien bieten die erstellten Bibliotheken einen schnellen Zugang zu gut bewerteten Pflanzenarten und Phytochemikalien mit potenziellen antibakteriellen Aktivitäten. Auf diese Weise können weitere Studien in noch unerforschten Richtungen mit den angegebenen oder ähnlichen Arten und Verbindungen durchgeführt werden. Darüber hinaus spielt die Verfügbarkeit von Substanzbibliotheken, die sich auf verwandte Bakterienarten konzentrieren, eine große Rolle bei den laufenden Bemühungen, die Regeln für die Penetration und Akkumulation von Antibiotika zu entwickeln, insbesondere bei gramnegativen Bakterien. Neben der Suche nach potenziellen Molekülgerüsten aus solchen Bibliotheken können detaillierte Bewertungen großer Pools von Verbindungen mit antibakteriellem Potenzial ein besseres Verständnis der strukturellen Merkmale ermöglichen, die für ihre Penetration und Akkumulation entscheidend sind. Da es kaum Verbindungen mit breiter struktureller Vielfalt und Aktivität gegen gramnegative Bakterien gibt, ist die Erstellung und Aktualisierung solcher Bibliotheken nach wie vor ein mühsames, aber wichtiges Unterfangen. Es wurde eine schnelle mikrowellenunterstützte Extraktionsmethode unter Druck (PMAE) und bei niedrigen Temperaturen entwickelt und mit der herkömmlichen Kaltmazeration mit längerer andauernd verglichen. Mit der PMAE-Methode sollten die wichtigsten Probleme herkömmlicher Extraktionsmethoden gelöst werden, die eine lange Extraktionsdauer erfordern, mehr Energie und Lösungsmittel verbrauchen und zudem größere Mengen an Pflanzenmaterial benötigen. Darüber hinaus sollte die Methode die übliche Verwendung hoher Temperaturen in den meisten der derzeitigen MAE-Anwendungen ersetzen. Interessanterweise lag die Ausbeute von 16 der 18 Pflanzenproben bei der 30-minütigen PMAE zwischen 91 und 139 % der jenigen, die bei der 24-stündigen Extraktion durch Mazeration erzielt wurde. Darüber hinaus wurden bei einem analytischen Vergleich der mit den beiden Methoden gewonnenen Extrakte unterschiedliche Selektivitätsgrade festgestellt. Obwohl jede Methode eine selektive Extraktion größere Mengen oder zusätzlicher Arten bestimmter Phytochemikalien anzeigte, wurde bei der Mazeration eine etwas größere Anzahl an Verbindungen beobachtet. Die Anwendung dieser PMAE-Methode ermöglicht eine effiziente Extraktion einer großen Anzahl von Proben, wobei hitzeempfindliche Verbindungen geschont werden und die Wahrscheinlichkeit von Kreuzreaktionen zwischen Phytochemikalien minimiert wird. Die weitere Untersuchung von Pflanzenextraktionen haben die geringe Reproduzierbarkeit von antibakteriellen Aktivitäten, die zuvor für verschiedene Pflanzenarten berichtet wurden, aufgedeckt, die Hauptursachen für die schlechte Reproduzierbarkeit identifiziert und mögliche Maßnahmen zur Minimierung dieser Herausforderung vorgeschlagen. Die Mehrheit der Extrakte zeigte bis zur höchsten getesteten Konzentration von 1024 µg/ml keine Aktivitäten. Bei identischen Pflanzenarten wurden nur bei 15 % der Extrakte gewisse Aktivitäten beobachtet, wobei die minimalen Hemmkonzentrationen (MHK) um das Vier- bis 16-fache höher waren als in früheren Berichten. Die Auswertung verwandter Pflanzenarten zeigte geringfügig bessere Ergebnisse, wobei etwa lagen 18 % der Extrakte Aktivitäten in einem Bereich von 128-512 µg/ml aufwiesen; dabei einige der Aktivitäten über denen, die zuvor bei verwandten Arten berichtet wurden. Darüber hinaus wurde die Löslichkeit von Pflanzenrohextrakten bei der Herstellung von Testlösungen für die Bestimmung der Antimikrobischen Suszeptibilität (AST) als eine der größten Herausforderungen bezeichnet. Bei dem Versuch, diese Herausforderung zu bewältigen, wurden in einigen Studien bakterientoxische Lösungsmittel oder allgemein inakzeptable Konzentrationen gängiger Lösungsvermittler verwendet. Beide Ansätze können zu falsch-positiven Ergebnissen führen. Deshalb hat diese Studie die Eignung von Aceton für die Solubilisierung von Pflanzenrohextrakten unterstrichen. Bei Verwendung von Aceton wurden eine bessere Löslichkeit der Pflanzenrohextrakten im Vergleich zu Dimethylsulfoxid (DMSO) bei bis zu 10 % v/v beobachtet. Aufgrund der fehlenden Toxizität gegen viele Bakterienarten bei bis zu 25 % v/v wird die Verwendung von Aceton für die Solubilisierung schwer wasserlöslicher Extrakte, insbesondere solcher aus weniger polaren Lösungsmitteln, befürwortet. In der nachfolgenden Untersuchung wurden vier Galloylglucosen aus den Blättern von Paeonia officinalis L. isoliert, wobei von drei Substanzen aus dieser Quelle zum ersten Mal berichtet wurde. Die Isolierung und Charakterisierung dieser Verbindungen wurden durch die dringende Notwendigkeit vorangetrieben, die präklinische Antibiotika-Pipeline mit allen verfügbaren Methoden zu füllen. Die Anwendung der bioautographisch gesteuerten Isolierung und einer Matrix aus extraktiven, chromatographischen, spektroskopischen und spektrometrischen Techniken ermöglichte die Isolierung der Verbindungen mit hohem Reinheitsgrad und die Bestimmung ihrer chemischen Strukturen. Darüber hinaus wiesen die Verbindungen minimale Hemmkonzentrationen (MHK) in einem Bereich von 2-256 µg/ml gegen multiresistente (MDR) Stämme von E. coli und K. pneumonia auf, die verschiedene MDR-Phänotypen aufweisen. Über die antibakteriellen Aktivitäten von drei der isolierten Verbindungen wurde zum ersten Mal berichtet. Die beobachteten In-vitro-Aktivitäten der Verbindungen stimmten mit ihren In-vivo-Potenzialen überein, die anhand des Galleria mellonella-Larvenmodells ermittelt wurden. Darüber hinaus wurde festgestellt, dass die Empfindlichkeit der MDR-Bakterien gegenüber den Galloylglucosen von der Art der von den MDR-Bakterien exprimierten Resistenzenzyme abhängt. So waren die Bakterien, die Enzyme mit einem höheren Gehalt an aromatischen Aminosäuren und null oder positiven Nettoladungen exprimieren, im Allgemeinen anfälliger. Nach diesen Erkenntnissen wurde eine plausible Hypothese für die beobachteten Muster aufgestellt. Die allgemein schwierigen pharmakokinetischen Eigenschaften von Galloylglucosen schränken ihre weitere Entwicklung als therapeutischen Wirkstoffen ein. Die Verbindungen können jedoch den Einsatz von Antibiotika in der Tierhaltung sowie bei der Behandlung von septischen Wunden und Infektionen der Haut oder der Mundhöhle ersetzen oder reduzieren, neben anderen potenziellen Anwendungen. Mit von der Natur inspirierten Ansätzen wurde eine Reihe von Glucovanillin-Derivaten synthetisch hergestellt. Einige der neuen Verbindungen wiesen MHK-Werte im Bereich von 128 - 512 μg/ml gegen empfindliche und MDR-Stämme von Klebsiella pneumoniae, Methicillin-resistentem Staphylococcus aureus (MRSA) und Vancomycin-resistentem Enterococcus faecium (VRE) auf. Diese Ergebnisse unterstreichen die bereits früher berichtete Bedeutung einer kleinen Molekülgröße, des Vorhandenseins protonierbarer Aminogruppen und Halogenatome sowie eines amphiphilen Charakters als entscheidende Merkmale für potenzielle antibakterielle Wirkstoffe. Da die Suche nach neuen antibakteriellen Wirkstoffen mit rein synthetischen Mitteln bisher nur begrenzt erfolgreich war, sind halbsynthetische Ansätze, wie sie in dieser Studie verwendet wurden, sehr zu empfehlen. Auf diese Weise ist es möglich, größere chemische Räume um natürliche Molekülgerüste herum zu erforschen und gleichzeitig deren inhärente Einschränkungen wie Löslichkeit, Toxizität und schlechte pharmakokinetische Profile zu überwinden. KW - Enterobacteriaceae KW - Pflanzen KW - Synthese KW - Multidrugresistant KW - Plant extracts KW - Isolation and Characterization KW - Microwave Assisted Extraction KW - Nature-Insipired Synthesis KW - Reproducibility challenges KW - Library of Phytochemicals KW - Library of plant species KW - Plants KW - Characterization KW - Synthesis Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-302632 ER - TY - JOUR A1 - Esken, Jens A1 - Goris, Tobias A1 - Gadkari, Jennifer A1 - Bischler, Thorsten A1 - Förstner, Konrad U. A1 - Sharma, Cynthia M. A1 - Diekert, Gabriele A1 - Schubert, Torsten T1 - Tetrachloroethene respiration in Sulfurospirillum species is regulated by a two‐component system as unraveled by comparative genomics, transcriptomics, and regulator binding studies JF - MicrobiologyOpen N2 - Energy conservation via organohalide respiration (OHR) in dehalogenating Sulfurospirillum species is an inducible process. However, the gene products involved in tetrachloroethene (PCE) sensing and signal transduction have not been unambiguously identified. Here, genome sequencing of Sulfurospirillum strains defective in PCE respiration and comparative genomics, which included the PCE‐respiring representatives of the genus, uncovered the genetic inactivation of a two‐component system (TCS) in the OHR gene region of the natural mutants. The assumption that the TCS gene products serve as a PCE sensor that initiates gene transcription was supported by the constitutive low‐level expression of the TCS operon in fumarate‐adapted cells of Sulfurospirillum multivorans. Via RNA sequencing, eight transcriptional units were identified in the OHR gene region, which includes the TCS operon, the PCE reductive dehalogenase operon, the gene cluster for norcobamide biosynthesis, and putative accessory genes with unknown functions. The OmpR‐family response regulator (RR) encoded in the TCS operon was functionally characterized by promoter‐binding assays. The RR bound a cis‐regulatory element that contained a consensus sequence of a direct repeat (CTATW) separated by 17 bp. Its location either overlapping the −35 box or 50 bp further upstream indicated different regulatory mechanisms. Sequence variations in the regulator binding sites identified in the OHR gene region were in accordance with differences in the transcript levels of the respective gene clusters forming the PCE regulon. The results indicate the presence of a fine‐tuned regulatory network controlling PCE metabolism in dehalogenating Sulfurospirillum species, a group of metabolically versatile organohalide‐respiring bacteria. KW - genomics KW - organohalide respiration KW - RNA sequencing KW - tetrachloroethene KW - transcriptomics KW - two‐component system Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-225754 VL - 9 IS - 12 ER - TY - JOUR A1 - Hampe, Irene A. I. A1 - Friedman, Justin A1 - Edgerton, Mira A1 - Morschhäuser, Joachim T1 - An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses JF - PLoS Pathogens N2 - The opportunistic fungal pathogen Candida albicans frequently produces genetically altered variants to adapt to environmental changes and new host niches in the course of its life-long association with the human host. Gain-of-function mutations in zinc cluster transcription factors, which result in the constitutive upregulation of their target genes, are a common cause of acquired resistance to the widely used antifungal drug fluconazole, especially during long-term therapy of oropharyngeal candidiasis. In this study, we investigated if C. albicans also can develop resistance to the antimicrobial peptide histatin 5, which is secreted in the saliva of humans to protect the oral mucosa from pathogenic microbes. As histatin 5 has been shown to be transported out of C. albicans cells by the Flu1 efflux pump, we screened a library of C. albicans strains that contain artificially activated forms of all zinc cluster transcription factors of this fungus for increased FLU1 expression. We found that a hyperactive Mrr1, which confers fluconazole resistance by upregulating the multidrug efflux pump MDR1 and other genes, also causes FLU1 overexpression. Similarly to the artificially activated Mrr1, naturally occurring gain-of-function mutations in this transcription factor also caused FLU1 upregulation and increased histatin 5 resistance. Surprisingly, however, Mrr1-mediated histatin 5 resistance was mainly caused by the upregulation of MDR1 instead of FLU1, revealing a previously unrecognized function of the Mdr1 efflux pump. Fluconazole-resistant clinical C. albicans isolates with different Mrr1 gain-of-function mutations were less efficiently killed by histatin 5, and this phenotype was reverted when MRR1 was deleted. Therefore, antimycotic therapy can promote the evolution of strains that, as a consequence of drug resistance mutations, simultaneously have acquired increased resistance against an innate host defense mechanism and are thereby better adapted to certain host niches. KW - antimicrobial resistance KW - transcriptional control KW - Candida albicans KW - transcription factors KW - mutation KW - hyperexpression techniques KW - antifungals KW - point mutation Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-158883 VL - 13 IS - 9 ER - TY - JOUR A1 - Sharan, Malvika A1 - Förstner, Konrad U. A1 - Eulalio, Ana A1 - Vogel, Jörg T1 - APRICOT: an integrated computational pipeline for the sequence-based identification and characterization of RNA-binding proteins JF - Nucleic Acids Research N2 - RNA-binding proteins (RBPs) have been established as core components of several post-transcriptional gene regulation mechanisms. Experimental techniques such as cross-linking and co-immunoprecipitation have enabled the identification of RBPs, RNA-binding domains (RBDs) and their regulatory roles in the eukaryotic species such as human and yeast in large-scale. In contrast, our knowledge of the number and potential diversity of RBPs in bacteria is poorer due to the technical challenges associated with the existing global screening approaches. We introduce APRICOT, a computational pipeline for the sequence-based identification and characterization of proteins using RBDs known from experimental studies. The pipeline identifies functional motifs in protein sequences using position-specific scoring matrices and Hidden Markov Models of the functional domains and statistically scores them based on a series of sequence-based features. Subsequently, APRICOT identifies putative RBPs and characterizes them by several biological properties. Here we demonstrate the application and adaptability of the pipeline on large-scale protein sets, including the bacterial proteome of Escherichia coli. APRICOT showed better performance on various datasets compared to other existing tools for the sequence-based prediction of RBPs by achieving an average sensitivity and specificity of 0.90 and 0.91 respectively. The command-line tool and its documentation are available at https://pypi.python.org/pypi/bio-apricot. KW - RNA-binding proteins KW - identification KW - characterization Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-157963 VL - 45 IS - 11 ER - TY - JOUR A1 - Mayr, Eva-Maria A1 - Ramírez-Zavala, Bernardo A1 - Krüger, Ines A1 - Morschhäuser, Joachim T1 - A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of Candida auris JF - mSphere N2 - ABSTRACT The recently emerged pathogenic yeast Candida auris is a major concern for human health, because it is easily transmissible, difficult to eradicate from hospitals, and highly drug resistant. Most C. auris isolates are resistant to the widely used antifungal drug fluconazole due to mutations in the target enzyme Erg11 and high activity of efflux pumps, such as Cdr1. In the well-studied, distantly related yeast Candida albicans, overexpression of drug efflux pumps also is a major mechanism of acquired fluconazole resistance and caused by gain-of-function mutations in the zinc cluster transcription factors Mrr1 and Tac1. In this study, we investigated a possible involvement of related transcription factors in efflux pump expression and fluconazole resistance of C. auris. The C. auris genome contains three genes encoding Mrr1 homologs and two genes encoding Tac1 homologs, and we generated deletion mutants lacking these genes in two fluconazole-resistant strains from clade III and clade IV. Deletion of TAC1b decreased the resistance to fluconazole and voriconazole in both strain backgrounds, demonstrating that the encoded transcription factor contributes to azole resistance in C. auris strains from different clades. CDR1 expression was not or only minimally affected in the mutants, indicating that Tac1b can confer increased azole resistance by a CDR1-independent mechanism. IMPORTANCE Candida auris is a recently emerged pathogenic yeast that within a few years after its initial description has spread all over the globe. C. auris is a major concern for human health, because it can cause life-threatening systemic infections, is easily transmissible, and is difficult to eradicate from hospital environments. Furthermore, C. auris is highly drug resistant, especially against the widely used antifungal drug fluconazole. Mutations in the drug target and high activity of efflux pumps are associated with azole resistance, but it is not known how drug resistance genes are regulated in C. auris. We have investigated the potential role of several candidate transcriptional regulators in the intrinsic fluconazole resistance of C. auris and identified a transcription factor that contributes to the high resistance to fluconazole and voriconazole of two C. auris strains from different genetic clades, thereby providing insight into the molecular basis of drug resistance of this medically important yeast." KW - Candida auris KW - fluconazole resistance KW - transcription factor Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-229937 VL - 5 IS - 2 ER - TY - JOUR A1 - Wallaschek, Nina A1 - Reuter, Saskia A1 - Silkenat, Sabrina A1 - Wolf, Katharina A1 - Niklas, Carolin A1 - Özge, Kayisoglu A1 - Aguilar, Carmen A1 - Wiegering, Armin A1 - Germer, Christoph-Thomas A1 - Kircher, Stefan A1 - Rosenwald, Andreas A1 - Shannon-Lowe, Claire A1 - Bartfeld, Sina T1 - Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids JF - PLoS Pathogens N2 - Epstein-Barr virus (EBV) is best known for infection of B cells, in which it usually establishes an asymptomatic lifelong infection, but is also associated with the development of multiple B cell lymphomas. EBV also infects epithelial cells and is associated with all cases of undifferentiated nasopharyngeal carcinoma (NPC). EBV is etiologically linked with at least 8% of gastric cancer (EBVaGC) that comprises a genetically and epigenetically distinct subset of GC. Although we have a very good understanding of B cell entry and lymphomagenesis, the sequence of events leading to EBVaGC remains poorly understood. Recently, ephrin receptor A2 (EPHA2) was proposed as the epithelial cell receptor on human cancer cell lines. Although we confirm some of these results, we demonstrate that EBV does not infect healthy adult stem cell-derived gastric organoids. In matched pairs of normal and cancer-derived organoids from the same patient, EBV only reproducibly infected the cancer organoids. While there was no clear pattern of differential expression between normal and cancer organoids for EPHA2 at the RNA and protein level, the subcellular location of the protein differed markedly. Confocal microscopy showed EPHA2 localization at the cell-cell junctions in primary cells, but not in cancer cell lines. Furthermore, histologic analysis of patient tissue revealed the absence of EBV in healthy epithelium and presence of EBV in epithelial cells from inflamed tissue. These data suggest that the EPHA2 receptor is not accessible to EBV on healthy gastric epithelial cells with intact cell-cell contacts, but either this or another, yet to be identified receptor may become accessible following cellular changes induced by inflammation or transformation, rendering changes in the cellular architecture an essential prerequisite to EBV infection. KW - Organoids KW - ephitelial cells KW - gastrointestinal infections KW - cancers and neoplasms KW - Epstein-Barr virus KW - flow cytometry KW - epithelium Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259206 VL - 17 IS - 2 ER -